Abstract:Cyclin-dependent kinase 8 (CDK8) and its regulatory partner Cyclin C (CycC) play conserved roles in modulating RNA polymerase II (Pol II)-dependent gene expression. To understand the structure and function relations of CDK8, we analyzed the structures of human and Drosophila CDK8 proteins using molecular dynamics simulations, combined with functional analyses in Drosophila. Specifically, we evaluated the structural differences between hCDK8 and dCDK8 to predict the effects of the LXXLL motif mutation (AQKAA), the P154L mutations, and drug binding on local structures of the CDK8 proteins. First, we have observed that both the LXXLL motif and the kinase activity of CDK8 are required for the normal larval-to-pupal transition in Drosophila. Second, our molecular dynamic analyses have revealed that hCDK8 has higher hydrogen bond occupation of His149-Asp151 and Asp151-Asn156 than dCDK8. Third, the substructure of Asp282, Phe283, Arg285, Thr287 and Cys291 can distinguish human and Drosophila CDK8 structures. In addition, there are two hydrogen bonds in the LXXLL motif: a lower occupation between L312 and L315, and a relatively higher occupation between L312 and L316. Human CDK8 has higher hydrogen bond occupation between L312 and L316 than dCDK8. Moreover, L312, L315 and L316 in the LXXLL motif of CDK8 have the specific pattern of hydrogen bonds and geometries, which could be crucial for the binding to nuclear receptors. Furthermore, the P154L mutation dramatically decreases the hydrogen bond between L312 and L315 in hCDK8, but not in dCDK8. The mutations of P154L and AQKAA modestly alter the local structures around residues 154. Finally, we identified the inhibitor-induced conformational changes of hCDK8, and our results suggest a structural difference in the drug-binding site between hCDK8 and dCDK8. Taken together, these results provide the structural insights into the roles of the LXXLL motif and the kinase activity of CDK8 in vivo.

What problem does this paper attempt to address?

The problems that this paper attempts to solve mainly include the following aspects: 1. **Study the relationship between the structure and function of CDK8**: Analyze the structures of human - and Drosophila - sourced CDK8 proteins through molecular dynamics simulations, and combine with the functional analysis in Drosophila to explore the structural characteristics and biological significance of its kinase domain, LXXLL motif, and drug - binding sites. 2. **Evaluate the effects of LXXLL motif mutation (AQKAA) and P154L mutation on the local structure of CDK8**: Specifically, study how these mutations affect the local structure of the CDK8 protein, especially the hydrogen - bond formation in the LXXLL motif region. 3. **Explore the roles of the LXXLL motif and kinase activity in the Drosophila development process**: Verify through transgenic experiments whether the LXXLL motif and kinase activity have an impact on the transformation process of Drosophila from larvae to pupae. 4. **Analyze the structural differences of drug - binding sites**: Compare the structural differences of human - and Drosophila - sourced CDK8 at drug - binding sites to understand the drug sensitivities of CDK8 in different species. ### Main findings - **The functional importance of the LXXLL motif**: The LXXLL motif is crucial for CDK8 to regulate the transformation process of Drosophila from larvae to pupae. The mutation of the LXXLL motif (AQKAA) causes Drosophila to die at the third - instar larval stage and fail to complete the pupation process. - **The importance of kinase activity**: Kinase activity is also necessary for CDK8 to regulate the transformation process of Drosophila from larvae to pupae. The P154L mutation (predicted to disrupt kinase activity) causes Drosophila to die at the pupal stage, and the transformation process from larvae to pupae is significantly delayed. - **Structural differences**: Molecular dynamics simulations show that human - sourced CDK8 (hCDK8) and Drosophila - sourced CDK8 (dCDK8) have differences in some local structures, especially in the hydrogen - bond formation in the LXXLL motif region. For example, the hydrogen bond formed between L312 and L316 in hCDK8 is more stable than that in dCDK8. - **The effects of mutations on hydrogen bonds**: The P154L mutation significantly reduces the hydrogen - bond formation between L312 and L315 in hCDK8, but has no obvious effect on dCDK8. In addition, the AQKAA mutation also changes the hydrogen - bond pattern in the LXXLL motif region. - **Structural differences of drug - binding sites**: There are differences in the structures of hCDK8 and dCDK8 at drug - binding sites, which may explain their differences in drug sensitivities. ### Conclusion These results provide important insights into the in - vivo functions and structural bases of the LXXLL motif and kinase activity in the CDK8 protein, and are helpful for further understanding the action mechanisms of CDK8 under different biological and pathological conditions.

All-Atomic Molecular Dynamic Studies of Human and Drosophila CDK8: Insights into Their Kinase Domains, the LXXLL Motifs, and Drug Binding Site

Highlighting the Major Role of Cyclin C in Cyclin-Dependent Kinase 8 Activity through Molecular Dynamics Simulations

Insights On Structural Characteristics And Ligand Binding Mechanisms Of Cdk2

Effect of Substituents in Different Positions of Aminothiazole Hinge-Binding Scaffolds on Inhibitor–CDK2 Association Probed by Interaction Entropy Method

Homology Modeling and Docking Study of Cyclin-Dependent Kinase (CDK) 10.

Reduced State Transition Barrier of CDK6 from Open to Closed State Induced by Thr177 Phosphorylation and Its Implication in Binding Modes of Inhibitors.

Molecular Principle of the Cyclin-Dependent Kinase Selectivity of 4-(Thiazol-5-yl)-2-(phenylamino) Pyrimidine-5-carbonitrile Derivatives Revealed by Molecular Modeling Studies.

Novel structural features of CDK inhibition revealed by an ab initio computational method combined with dynamic simulations

Molecular Mechanism of Mutational Disruption of DCLK1 Autoinhibition Provides a Rationale for Inhibitor Screening

Molecular Mechanism Concerning Conformational Changes of CDK2 Mediated by Binding of Inhibitors Using Molecular Dynamics Simulations and Principal Component Analysis

Elucidating Binding Selectivity in Cyclin-Dependent Kinases (CDKs) 4, 6, and 9: Development of Highly Potent and Selective CDK4/9 Inhibitors

Using 3D-QSAR and Molecular Docking Insight into Inhibitors Binding with Complex-Associated Kinases CDK8

An in silico exploration of the interaction mechanism of pyrazolo[1,5-a]pyrimidine type CDK2 inhibitors.

CDK8 as a therapeutic target for cancers and recent developments in discovery of CDK8 inhibitors

Homology Modeling, Molecular Dynamic Simulation and Docking Studies of Cyclin Dependent Kinase 1

High-throughput discovery and deep characterization of cyclin-CDK docking motifs

Unveiling Conformational States of CDK6 Caused by Binding of Vcyclin Protein and Inhibitor by Combining Gaussian Accelerated Molecular Dynamics and Deep Learning

Cooperation of structural motifs controls drug selectivity in cyclin-dependent kinases: an advanced theoretical analysis

CDK2 and CDK4: Cell Cycle Functions Evolve Distinct, Catalysis-Competent Conformations, Offering Drug Targets

Computational Study of Non-Catalytic T-loop Pocket on CDK Proteins for Drug Development

Computational Analysis for Residue-Specific CDK2-Inhibitor Bindings